Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Anti-inflammation Treatment for Idiopathic Inflammatory Myopathies

NCT07668505 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT07668505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07668505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Anti-inflammation Treatment for Idiopathic Inflammatory Myopathies
Lead sponsor
Chinese University of Hong Kong
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
August 31, 2029
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myositis